Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 221-230 of 492 for sleep

Edit search filters
  1. A Trial To Compare Nintedanib With Placebo For Patients With Scleroderma Related Lung Fibrosis

    Rochester, MN

  2. A Study Comparing Sublobar Resection Versus Stereotactic Ablative Radiotherapy For Lung Cancer

    Rochester, MN

  3. The Medtronic Harmony™ Transcatheter Pulmonary Valve Clinical Study

    Rochester, MN

  4. A Study To Evaluate The Effectiveness And Safety Of Pamrevlumab In Patients With Idiopathic Pulmonary Fibrosis

    Jacksonville, FL

  5. A Study To Investigate Mepolizumab In The Treatment Of Eosinophilic Granulomatosis With Polyangiitis

    Rochester, MN

  6. A Study Of Inhaled Molgramostim In Cystic Fibrosis Subjects With Nontuberculous Mycobacterial (NTM) Infection

    Rochester, MN

  7. A Study To Evaluate Protective Ventilation With High Versus Low PEEP During One-lung Ventilation For Thoracic Surgery

    Jacksonville, FL

  8. A Study Of Biomarker-Directed, Pembrolizumab (MK-3475) Based Combination Therapy For Advanced Non-Small Cell Lung Cancer (MK-3475-495)

    Jacksonville, FL, Rochester, MN

  9. A Study Of LJPC-501 In Patients With Catecholamine-Resistant Hypotension

    Rochester, MN

  10. A Study To Evaluate Firstline Pembrolizumab Alone Or In Combination With Pemetrexed And Carboplatin In Induction/Maintenance Or Postprogression In Treating Patients With Stage IV Non-squamous Non-small Cell Lung Cancer

    Albert Lea, MN, Eau Claire, WI, Jacksonville, FL, La Crosse, WI, Mankato, MN, Rochester, MN

.

Mayo Clinic Footer